Sponsors

Creating better health for people and a brighter future for the world is Takeda’s purpose. The science and technology we advance are constantly evolving, but through our enduring values our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people.

The work we do transforms lives, helping patients with limited or no treatment options in our core therapeutic and business areas of gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. We’re taking on big challenges that require new ways of thinking based on the unique needs of patients – including innovating across our operations and value chain, increasing tailored access solutions to the medications and vaccines we produce while helping address disparities within the health care ecosystem.

We are building one of the most exciting and diverse pipelines in the industry. We follow science and aim to unlock innovation wherever it originates – whether we are developing a therapy in one of our laboratories or through our more than 200 partnerships. Together with our investments in data and digital technologies, we aim to improve the patient experience and revolutionize our approach to science.

Takeda is headquartered in Tokyo with a global hub in Cambridge, Massachusetts. We have a presence in approximately 80 countries and regions, a network of manufacturing sites around the world, and major research centers in Japan and the United States. Our global scale and strong portfolio of transformative treatments have and will continue to generate momentum and fuel innovation.

Sanofi:

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.

Regeneron:

Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments, almost all of which were homegrown in our laboratories.

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the research, diagnosis, and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services. The Group’s extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets), offers patients innovative solutions to improve quality of life for people with allergies. A world leader in allergen immunotherapy, Stallergenes Greer has an extensive global footprint and the largest allergen and finished AIT product manufacturing capacity globally.

Our purpose is to enable precision medicine to improve life for people with allergies. Our strategy is designed to achieve our ambition of being the world’s leading allergen immunotherapy company for the long-term and deliver sustainable value to all our stakeholders: patients, the medical community, healthcare systems, colleagues, and our shareholder. To achieve our ambition, our strategy is based on four pillars:

• Excellence in execution: to serve patients with high-quality products and optimal solutions to treat allergies thanks to a robust supply chain and state-of-the-art pharmaceutical technologies,
• Strengthening our core business: expanding our geographical footprint to reach more patients in need of precise, personalised treatments, by offering the broadest portfolio of allergens and delivery systems.
• Developing new solutions for patients: for the benefit of patients across the globe, through the generation of the evidence of our treatments with new clinical and real-world data,
• Attracting and developing talents: investing in the development of our colleagues, committed to improving the quality of life of allergy sufferers.

Menarini Asia-Pacific is a member of the Menarini Group, the world's largest Italian biopharmaceutical company with a heritage of over 130 years and over 17,000 employees in more than 140 countries. Here in Asia-Pacific, Menarini's vision is to be a leading provider of important healthcare brands to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval, and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including

Consumer Health, Dermatology, Allergy/Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology/Specialty Care and Men's Health. For more information, visit www.menariniapac.com

EUROIMMUN is a leading manufacturer of medical laboratory products for allergy, autoimmune, infection and molecular diagnostics. EUROIMMUN’s in vitro allergy diagnostics portfolio includes a comprehensive spectrum of allergen extracts in more than 65 EUROLINE profiles for efficient multiparameter detection of specific IgE antibodies. Products encompass indication-oriented profiles (e.g. food, inhalation, atopy, insect venoms or pediatrics), as well as region-specific profiles which take into account local allergen exposure. The product range is complemented by selected profiles for molecular allergy diagnostics (peanut, milk, pediatric food allergies, insect venoms, pollens). These allow differentiation of primary sensitisations from cross reactions, as well as high-risk from low-risk reactions. The allergy product range is complemented by flexible automation solutions.

BioLegend creates world-class, cutting-edge antibodies and reagents across a diverse set of applications—from flow cytometry to immunoassays to multiomics.

We’re accelerating research and discovery by providing high-quality, purpose-driven products for outstanding value. With 30,000 trusted reagents, 100,000+ citations in peer-reviewed publications, and a dedicated team to create custom solutions for your lab, there’s nothing our expertise doesn’t cover. Discover the BioLegend difference and see how it can make an impact in your lab. Learn more at bioLegend.com.